Leadership Insights - Panel
Heather Morel, VP/GM McKesson Specialty Health, Dr. Jeffrey Trent, CEO and Chief Scientific Officer, TGen, Michele Y. Halyard, M.D, vice dean, Mayo Medical School – Arizona Campus, Dr. Ronald Korn, Medical Director, Virginia G. Piper cancer Center.
Finding a Solution for Valley Fever
David Larwood, CEO, Valley Fever Solutions Bringing new compounds and diagnostics to help detect and treat Valley Fever. VFS has received good support from government grants, and collaborates closely with the Valley Fever Center for Excellence, vfce.arizona.edu. We are moving towards Phase II trials in humans of Nikkomycin-Z, a compound that shows great promise in treating humans or animals infected with Valley Fever.
Announcing Grants for Emerging Medical Device Companies
Arizona has one of the fastest growing bioscience communities in the US; annual total economic activity is now $28.8 billion. It has a particularly robust medical device sector, which constitutes 32% of Arizona’s non-hospital bioscience employment. With first-class research institutions and an industry spanning from one-person shops to industry giants, Arizona has it all.To support this critically important sector, the City of Peoria, Arizona, BioAccel and The Plaza Companies have created BioInspire™, an incubator in Peoria dedicated to medical device development that provides working capital and space to qualifying companies. More than just a facility, this collaboration was created to connect the medical device community.
Daniel Von Hoff Keynote
Daniel Von Hoff, MD, FACP Daniel D. Von Hoff, M.D., F.A.C.P., is currently Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Chief Scientific Officer for US Oncology and for Scottsdale Healthcare's Clinical Research Institute. He is also a Clinical Professor of Medicine, University of Arizona.